Sandbox/Alejandro: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 1: Line 1:
{| style="border: 0px; font-size: 85%; margin: 3px;" align=center
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
|+ '''Criteria for suspected MERS-CoV infection<ref>“CDC-MERS-Interim Guidance.” Accessed June 20, 2014. http://www.cdc.gov/coronavirus/mers/interim-guidance.html.</ref>'''
|+
| align="center" style="background:#4479BA; width:500px" colspan=2|{{fontcolor|#FFF|'''Patients should meet the following criteria, either A or B'''}}
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF|Tuberculin Rection}}
! style="background: #4479BA; width: 450px;" | {{fontcolor|#FFF|Considered a Positive Result in:}}
|-
|-
|style="padding: 5px 5px; background: #DCDCDC;width:250px" |'''A.'''&nbsp;&nbsp; [[ Fever]] (≥38°C, 100.4°F) and [[pneumonia]] or [[acute respiratory distress syndrome]] (based on clinical or radiological evidence)
| style="padding: 5px 5px; background: #DCDCDC;" | '''≥ 5 mm '''
|style="padding: 5px 5px; background: #DCDCDC;width:250px" |'''B.'''&nbsp;&nbsp; [[Fever]] (≥38°C, 100.4°F)
| style="padding: 5px 5px; background: #F5F5F5;" |
*HIV-positive person
*Recent contacts of TB case
*Persons with nodular or fibrotic changes on CXR consistent with old healed TB
*Patients with organ transplants and other immunosuppressed patients
|-
|-
|style="padding: 5px 5px; background: #F5F5F5; text-align:center" |''AND EITHER''
| style="padding: 5px 5px; background: #DCDCDC;" | '''≥ 10 mm  '''
|style="padding: 5px 5px; background: #F5F5F5;text-align:center" |''AND''
| style="padding: 5px 5px; background: #F5F5F5;" |  
*Recent arrivals (less than 5 years) from high-prevalent countries
*Injection drug users
*Residents and employees of high-risk congregate settings (e.g., prisons, nursing homes, hospitals, homeless shelters, etc.)
*Mycobacteriology lab personnel
*Persons with clinical conditions that place them at high risk (e.g., diabetes, prolonged corticosteroid therapy, leukemia, end-stage renal disease, chronic malabsorption syndromes, low body weight, etc)
*Children less than 4 years of age, or children and adolescents exposed to adults in high-risk categories
|-
|-
|style="padding: 5px 5px; background: #DCDCDC;" |&nbsp;&nbsp;&nbsp; • History of travel from countries in or near the Arabian Peninsula within 14 days before symptom onset
| style="padding: 5px 5px; background: #DCDCDC;" | '''≥ 15 mm '''
|style="padding: 5px 5px; background: #DCDCDC;" |&nbsp;&nbsp;&nbsp; • Symptoms of respiratory illness (not necessarily pneumonia; e.g., [[cough]], [[shortness of breath]])
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
*Persons with no known risk factors for TB
|style="padding: 5px 5px; background: #F5F5F5;text-align:center" |''OR''
|style="padding: 5px 5px; background: #F5F5F5;text-align:center" |''AND''
|-
|style="padding: 5px 5px; background: #DCDCDC;" |&nbsp;&nbsp;&nbsp; • Close contact with a symptomatic traveler who developed [[fever]] and acute [[respiratory illness]] (not necessarily [[pneumonia]]) within 14 days after traveling from countries in or near the Arabian Peninsula
|style="padding: 5px 5px; background: #DCDCDC;" |&nbsp;&nbsp;&nbsp; •  Being in a healthcare facility (as a patient, worker, or visitor) within 14 days before symptom onset in a country or territory in or near the Arabian Peninsula in which recent healthcare-associated cases of MERS have been identified
|-
|style="padding: 5px 5px; background: #F5F5F5;text-align:center" |''OR''
|style="padding: 5px 5px; background: #F5F5F5;text-align:center" |
|-
|style="padding: 5px 5px; background: #DCDCDC;" |&nbsp;&nbsp;&nbsp; • Member of a cluster of patients with severe acute [[respiratory illness]] (e.g.[[ fever]] and [[pneumonia]] requiring hospitalization) of unknown [[etiology]] in which [[MERS-CoV]] is being evaluated, in consultation with state and local health departments
|style="padding: 5px 5px; background: #DCDCDC;" |
|-
|-
|}
|}

Latest revision as of 13:10, 4 September 2014

Tuberculin Rection Considered a Positive Result in:
≥ 5 mm
  • HIV-positive person
  • Recent contacts of TB case
  • Persons with nodular or fibrotic changes on CXR consistent with old healed TB
  • Patients with organ transplants and other immunosuppressed patients
≥ 10 mm
  • Recent arrivals (less than 5 years) from high-prevalent countries
  • Injection drug users
  • Residents and employees of high-risk congregate settings (e.g., prisons, nursing homes, hospitals, homeless shelters, etc.)
  • Mycobacteriology lab personnel
  • Persons with clinical conditions that place them at high risk (e.g., diabetes, prolonged corticosteroid therapy, leukemia, end-stage renal disease, chronic malabsorption syndromes, low body weight, etc)
  • Children less than 4 years of age, or children and adolescents exposed to adults in high-risk categories
≥ 15 mm
  • Persons with no known risk factors for TB